Article
Chronic Graft-vs-Host Disease
18 Nov 2003
Abstract excerpt
ALLOGENEIC HEMATOPOIETIC cell transplantation (HCT) is a treatment used increasingly for a variety of malignant and nonmalignant diseases of the bone marrow and immune system. Although the procedure cures many patients with otherwise incurable diseases, it is often associated with serious immunological complications, particularly graft-vs-host disease (GVHD). A chronic form of GVHD afflicts many allogeneic HCT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
